+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Carbapenem"

Enzymes for Antibiotic Synthesis Market - Global Forecast 2026-2032 - Product Thumbnail Image

Enzymes for Antibiotic Synthesis Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 188 Pages
  • Global
From
Enzymes for ß-lactam Antibiotics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Enzymes for ß-lactam Antibiotics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 196 Pages
  • Global
From
Carbapenem-Resistant Enterobacteriaceae (CRE) Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Carbapenem-Resistant Enterobacteriaceae (CRE) Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Beta Lactam and Beta Lactamase Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Beta Lactam and Beta Lactamase Inhibitors - Global Strategic Business Report

  • Report
  • February 2026
  • 391 Pages
  • Global
From
Penicillin Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Penicillin Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • January 2026
  • 120 Pages
  • Global
From
Antibiotics Market Size, Share, Trends and Forecast by Action Mechanism, Drug Class, Spectrum of Activity, Route of Administration, End User, and Region, 2025-2033 - Product Thumbnail Image

Antibiotics Market Size, Share, Trends and Forecast by Action Mechanism, Drug Class, Spectrum of Activity, Route of Administration, End User, and Region, 2025-2033

  • Report
  • September 2025
  • 144 Pages
  • Global
From
Beta-Lactamase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Beta-Lactamase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Antibiotic Resistance Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Antibiotic Resistance Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • July 2025
  • 215 Pages
  • Global
From
Cephalosporin Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Cephalosporin Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • October 2025
  • 160 Pages
  • Global
From
Peptide Antibiotics Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Peptide Antibiotics Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • October 2025
  • 160 Pages
  • Global
From
Pseudomonas Aeruginosa Infection Treatment: Market Share, and Growth Analysis by Product Type (Antibiotics, Antiseptics, Vaccines), Application, End User, Technology - Product Thumbnail Image

Pseudomonas Aeruginosa Infection Treatment: Market Share, and Growth Analysis by Product Type (Antibiotics, Antiseptics, Vaccines), Application, End User, Technology

  • Report
  • August 2025
  • 150 Pages
  • Global
From
Beta-Lactam and Beta-Lactamase Inhibitor Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Beta-Lactam and Beta-Lactamase Inhibitor Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • March 2025
  • 150 Pages
  • Global
From
Antibiotics Market - Product Thumbnail Image

Antibiotics Market

  • Report
  • October 2025
  • 83 Pages
  • Global
From
U.S. Antibiotics Market Size, Share & Trends Analysis Report By Action Mechanism (Cell Wall, Protein, DNA, RNA), By Type (Branded Antibiotics, Generic Antibiotics), By Drug Class (Cephalosporins, Penicillin, Carbapenems), And Segment Forecasts, 2025 - 2030 - Product Thumbnail Image

U.S. Antibiotics Market Size, Share & Trends Analysis Report By Action Mechanism (Cell Wall, Protein, DNA, RNA), By Type (Branded Antibiotics, Generic Antibiotics), By Drug Class (Cephalosporins, Penicillin, Carbapenems), And Segment Forecasts, 2025 - 2030

  • Report
  • July 2025
  • 100 Pages
  • United States
From
Antibiotics Market Report 2023-2033 - Product Thumbnail Image

Antibiotics Market Report 2023-2033

  • Report
  • January 2023
  • 388 Pages
  • Global
From
Carbapenem Market Size, Share & Trends Analysis Report By Drug Class (Meropenem, Imipenem, Ertapenem), By Application (UTI, Blood Stream Infections, Pneumonia), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Carbapenem Market Size, Share & Trends Analysis Report By Drug Class (Meropenem, Imipenem, Ertapenem), By Application (UTI, Blood Stream Infections, Pneumonia), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 236 Pages
  • Global
From
Europe Antibiotics Market Size, Share & Trends Analysis Report by Drug Class (Cephalosporin, Penicillin), Type (Branded Antibodies, Generic Antibodies), Action Mechanism, Country, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Europe Antibiotics Market Size, Share & Trends Analysis Report by Drug Class (Cephalosporin, Penicillin), Type (Branded Antibodies, Generic Antibodies), Action Mechanism, Country, and Segment Forecasts, 2024-2030

  • Report
  • March 2024
  • 80 Pages
  • Europe
From
Beta Lactam and Beta Lactamase Inhibitors Market 2025-2029 - Product Thumbnail Image

Beta Lactam and Beta Lactamase Inhibitors Market 2025-2029

  • Report
  • December 2024
  • 200 Pages
  • Global
From
Carbapenem-resistant Enterobacteriaceae Infection - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Carbapenem-resistant Enterobacteriaceae Infection - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Antibiotics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Antibiotics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 100 Pages
  • Global
From
Loading Indicator

The Carbapenem market is a subset of the Antibiotics market, which is composed of drugs used to treat bacterial infections. Carbapenems are a class of antibiotics that are used to treat serious infections caused by bacteria that are resistant to other antibiotics. They are typically used as a last resort when other antibiotics have failed. Carbapenems are generally well-tolerated and have a low risk of side effects. Carbapenems are used to treat a wide range of infections, including pneumonia, urinary tract infections, and skin and soft tissue infections. They are also used to treat infections caused by multidrug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). The Carbapenem market is highly competitive, with several major players. These include Merck & Co., Pfizer, GlaxoSmithKline, AstraZeneca, and Sanofi. Other companies in the market include Allergan, Novartis, and Daiichi Sankyo. Show Less Read more